S1810 Cholecystokin Enhances Noxious Stimulation Evoked Visceral Pain Affective Memory Encoded in the Anterior Cingulated Cortex

Shengliang Chen,Liyan Zhang,Xiao Dong,Zhongliang Liu,Juan Li,Zhijun Cao,Jingyuan Fang,Jianzhong Mo,Shudong Xiao,Ying Li
DOI: https://doi.org/10.1016/s0016-5085(10)61281-4
IF: 29.4
2010-01-01
Gastroenterology
Abstract:inter-stimulus) and the visceromotor response (VMR) assessed.After the first CRD, rats were treated with biphenyl-3-yl cyclohexylcarbamate] (3 mg/kg, SC route) or vehicle (PO route).Two hours later, rats were treated with cortagine (10 μg/kg, IP route).After 15 min, a second CRD was performed.Thirty min after the second CRD, rats were anesthetized with isoflurane, decapitated, and brains collected along with those from naïve rats (no CRD, no treatment).AEA and 2-AG levels were quantified in brain extracts by LC-MS/MS.Results: In vehicle-treated rats, cortagine increased the VMR to CRD at 40 and 60 mmHg to 130 ± 20% and 144 ± 14% of baseline, respectively.URB597 blocked the cortagine-induced increase in VMR at 60 mmHg (95 ± 20% vs. 144 ± 14%, p<0.05) and showed a trend for reduction at 40 mmHg.URB597 also decreased the percentage of cortagine treated rats with an increased VMR (45 and 36% of URB597-treated rats at 40 and 60 mmHg vs. 84 and 92% with vehicle, p<0.05).URB597 increased brain AEA levels 5.7-fold (p<0.001) in rats compared to vehicle treatment and significantly elevated levels of other FAAH substrates.AEA levels in vehicle-treated rats were similar to those of naïve rats indicating that vehicle, CRD, and cortagine did not affect the basal levels of AEA in the brain.2-AG levels showed little or no significant change among all 3 groups of rats.Conclusions: These data support a role of eCBs in the control of visceral hypersensitivity induced by CRF 1 signaling activation and suggest that FAAH inhibitors may represent a promising therapy for IBS-D.
What problem does this paper attempt to address?